|
|
||||||||
1 Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusets 02115; and 2 Pfizer Global Research and Development, Groton, Connecticut 06340
| |
ABSTRACT |
|---|
|
|
|---|
Signaling through the protein phosphatase calcineurin may play a critical role in cardiac hypertrophy. The gene for Down Syndrome Critical Region-1 (DSCR1) encodes a protein that is an endogenous calcineurin inhibitor. This study was designed to test the hypothesis that DSCR1 is directly induced by biomechanical stimuli. Neonatal rat cardiac myocytes were exposed to biaxial cyclic mechanical strain; mechanical strain upregulated DSCR1 mRNA expression in a time- and amplitude-dependent manner (3.4 ± 0.2-fold at 8% strain for 6 h, n = 11, P < 0.01), and this induction was angiotensin II and endothelin I independent. Biomechanical induction of DSCR1 mRNA was partially blocked by calcineurin inhibition with cyclosporine A (30 ± 5%, n = 3, P < 0.01). DSCR1 promoter-reporter experiments showed that mechanical strain induced DSCR1 promoter activity by 2.3-fold and that this induction was completely inhibited by cyclosporin A. Furthermore, DSCR1 gene expression was increased in the left ventricles of mice with pressure-overload hypertrophy induced by transverse aortic banding. These data demonstrate that biomechanical strain directly induces gene expression for the calcineurin inhibitor DSCR1 in cardiac myocytes, indicating that mechanically induced DSCR1 may regulate the hypertrophic response to mechanical overload.
hypertrophy; mechanical strain
| |
INTRODUCTION |
|---|
|
|
|---|
CARDIAC HYPERTROPHY, a major risk factor for cardiac morbidity and mortality (13), is an adaptive response to a broad variety of cardiovascular stresses. Whereas multiple factors likely participate in cardiac hypertrophy, including neurohormonal factors and mutations in genes for sarcomere proteins, biomechanical forces play a prominent role (12, 21). The hypertrophic response to mechanical overload may be initially beneficial, but through incompletely described processes, cardiac hypertrophy can be maladaptive and progress to heart failure.
The Down Syndrome Critical Region-1 gene [DSCR1, also known as MCIP1
(6, 7, 9, 20, 28)] on human chromosome 21 is highly
expressed in the brain, heart, and skeletal muscle and encodes a
protein that interacts physically and functionally with calcineurin A,
the catalytic subunit of the Ca2+/calmodulin-dependent
protein phosphatase (PP2B) (10). Recent studies showed
that overexpression of DSCR1 in hearts of transgenic mice attenuates
hypertrophic responses to
-adrenergic receptor stimulation or
exercise training and prevents progression to dilated cardiomyopathy
that otherwise results from chronic activation of calcineurin in the
myocardium (19). Because calcineurin participates in
signal transduction leading to cardiac hypertrophy (17), we tested the hypothesis that DSCR1 is directly induced in cardiac myocytes in response to biomechanical strain. Our results demonstrate that biomechanical strain directly induces DSCR1 gene expression, suggesting a negative feedback mechanism to regulate calcineurin activity during the hypertrophic response to biomechanical stimuli.
| |
METHODS |
|---|
|
|
|---|
Culture and biomechanical strain of myocytes. Neonatal rat ventricular myocytes (NRVMs) from 1-day-old Harlan Sprague-Dawley rats were isolated by previously described methods (24). Mechanical deformation was applied to a thin and transparent membrane on which cells were cultured, an approach that produces controlled biaxially uniform cellular strain as well as visualization of cells (2). After 24 h of being plated in Dulbecco's modified Eagle's medium (DMEM) containing 7% fetal bovine serum, NRVMs were washed twice with phosphate-buffered saline and made quiescent by incubating with DMEM containing 1% ITS (insulin-transferrin-sodium selenite, Sigma) supplement for ~48 h, because the signal-to-noise ratio is more prominent in quiescent cells in response to strain. To eliminate the variable of time-dependent changes due to cell age or effects of adhesion, in each experiment, all cells were cultured on the membrane for an identical time period, and cells and media from all samples were harvested at the same time. For example, in a time course experiment with strain, the time point represents the time before harvest that strain was initiated, such that the strain sample and control sample were harvested at the same time.
Animal studies. The Harvard Medical School Standing Committee on Animal Research approved the study protocol. Pressure overload was produced by transverse aortic constriction. Male FVB mice (age 8-10 wk) were anesthetized with pentobarbital (25-30 µg/g ip), and the transverse aorta was constricted by tying a 7-0 nylon suture around the vessel against a blunted 27-gauge needle with the aid of a dissecting microscope. The needle was removed, and, after recovery, hypertrophy was measured by weekly echocardiograms. In the mice used for this study, mean left ventricular mass-body weight in banded mice compared with sham mice increased by 40% at 4 wk and 64% at 12 wk; these changes are comparable to increases measured in a large cohort of mice in our laboratory followed prospectively with blinded echocardiograms (data not shown).
Northern and Western blot analyses. Northern blot analysis was performed and analyzed as previously described (24). Purified RNA (1 µg) was used for the synthesis of the 600-base pair DSCR1 cDNA probe. Western analysis was performed using a polyclonal antibody against calcineurin A (Santa Cruz, CA) (2).
Calcineurin activity assay. Calcineurin activity was assayed using a cellular calcineurin assay kit from BioMol according to the manufacturer's protocol. Phosphatase activity was measured as the dephosphorylation rate of a synthetic phosphopeptide substrate (RII peptide). The amount of PO4 released was determined colorimetrically with the BioMol green reagents.
Promoter assays.
The human DSCR1 promoter construct containing the luciferase
reporter was kindly provided by Dr. R. Sanders Williams from Duke
University (28). Cardiac myocytes were transfected with each reporter plasmid (15 µg) by using the calcium phosphate
precipitation method (24). As an internal control for
transfection efficiency, a cytomeglovirus
-gal plasmid (2 µg) was
cotransfected in all experiments. Cells were subjected to mechanical
strain 48 h after transfection, and lysates were prepared 24 h later for luciferase and
-galactosidase assays as described by the
manufacturer (Applied Biosystems; Bedford, MA). The relative luciferase
activity was calculated as the ratio of luciferase to
-galactosidase
activities and standardized to the basal activity of the unstimulated
874 to +30 DSCR1 (MCIP1) luciferase reporter construct (fold induction).
Statistics. Data are presented as means ± SE and were analyzed by Student's t-tests or ANOVA. A value of P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Mechanical induction of DSCR1.
Cyclic biomechanical strain (8%, 1 Hz) induced DSCR1 mRNA accumulation
in a time-dependent manner in cardiac myocytes, reaching a maximum at
3 h and persisting for at least 24 h (Fig.
1, A and B). The
DSCR1 mRNA level after 6 h of mechanical strain was increased 3.4 ± 0.2-fold (n = 11, P < 0.01). In addition, when NRVMs were subjected to cyclic biaxial strains
of 2, 4, 8, or 12% at 1 Hz for 5 h, the induction of DSCR1 mRNA
expression in NRVMs was amplitude dependent (Fig. 1C).
|
Effects of mechanical strain on the stability of DSCR1 mRNA.
To determine whether mechanical strain increased DSCR1 mRNA
accumulation by increasing the rate of synthesis or by decreasing the
rate of degradation, NRVMs were exposed to 0% or 8% strain for 6 h and then incubated further with actinomycin D (5 µg/ml) to inhibit
transcriptional activity. The half-life of DSCR1 mRNA was not affected
by mechanical strain (2.98 ± 0.12 h vs. 2.87 ± 0.27 h of unstretched cells, P > 0.05, n = 3) (Fig. 2). These experiments suggest that mechanical strain increases the rate of
synthesis of DSCR1 mRNA.
|
Effects of neurohormonal factors and cytokines on the induction of
DSCR1 mRNA.
To determine whether the effect of cyclic mechanical strain on DSCR1
mRNA expression in NRVMs is angiotensin II or endothelin dependent, NRVMs were subjected to 8% cyclic strain at 1 Hz for 6 h in the presence or absence of an AT1 receptor or
endothelin receptor antagonist. CP-191,166 (0.1 µM), an
AT1 receptor antagonist, or PD-145065 (1 µM), an
endothelin receptor antagonist, had no significant effect on DSCR1 mRNA
induction by cyclic mechanical strain (Fig.
3, A and B).
|
(TNF-
) caused a
marginal increase in DSCR1 mRNA expression (Fig. 3, C and
D).
Protein kinase C and MAP kinases in mechanical induction of DSCR1.
Mechanical strain activates protein kinase C (PKC) and
mitogen-activated protein (MAP) kinases in cardiac myocytes (11, 24-27). Calphostin C (1 µM), a selective PKC inhibitor
(24), did not inhibit DSCR1 mRNA induction by strain (Fig.
4). In addition, neither PD-98059 (50 µM), a MAP kinase kinase inhibitor (24), nor SB-203580
(10 µM), a p38 MAP kinase inhibitor (24), inhibited the
effect of mechanical strain (Fig. 4). These findings suggest that the
PKC and MAP kinase pathways do not mediate mechanical induction of
DSCR1 expression.
|
Role of Ca2+ in mechanical induction
of DSCR1.
Because mechanical strain increases intracellular Ca2+ in
cardiac myocytes (1), experiments were performed to
examine the effect of manipulation of intracellular Ca2+
concentrations on mechanical induction of DSCR1 expression. NRVMs were preincubated with the cell membrane-permeable Ca2+
chelator BAPTA-AM (10 µM) for 30 min and then exposed to 0 or 8% strain at 1 Hz for 6 h. Northern analysis showed that
BAPTA-AM completely blocked mechanical induction of DSCR1 mRNA
expression (Fig. 5 A and
B). In addition, the Ca2+ ionophore A23187 (10 µM) induced DSCR1 mRNA expression. These data suggest that induction
of DSCR1 expression by mechanical strain is mediated by intracellular
Ca2+ signaling.
|
Calcineurin and induction of DSCR1.
It was recently reported that overexpression of constitutively active
calcineurin A upregulates DSCR1 gene expression in C2C12 myogenic cells
(28). To investigate participation of calcineurin in
mechanical induction of DSCR1 in cardiomyocytes, NRVMs were exposed to
8% cyclic strain at 1 Hz for 6 h in the presence or absence of
cyclosporin A (1 µM), a calcineurin inhibitor. Cyclosporin A
pretreatment partially attenuated mechanical induction of DSCR1 mRNA
(30 ± 5%, n = 3, P < 0.01)
(Fig. 6A). Cyclosporin A also blocked LIF-induced DSCR1 induction by 35 ± 4%
(n = 3, P < 0.01).
|
Effects of mechanical strain on DSCR1 promoter activity.
Yang et al. (28) recently showed that an intragenic region
between exon 3 and exon 4 of the DSCR1 gene contains a dense cluster of
consensus NF-AT binding motifs (T/AGGAAANA/T/C) that are responsive to
calcineurin activation. To determine whether these transcriptional
regulatory elements are mechanically responsive, NRVMs were transfected
with a DSCR1-luciferase reporter construct containing the consensus
nuclear factor of activated T cells (NF-AT) binding motifs
(
874 to +30 relative to the first nucleotide of exon 4). As showed in
Fig. 7, the reporter activity was
stimulated 2.3-fold by mechanical strain, and this was abolished by
cyclosporin A (1 µM) pretreatment, indicting that mechanical
stimulation of the DSCR1 promoter is mediated by activation of
calcineurin.
|
Induction of DSCR1 in pressure-overload hypertrophy.
To determine whether DSCR1 is mechanically induced in vivo, we studied
the effect of pressure overload on DSCR1 mRNA induction in a mouse
model of pressure-overload hypertrophy induced by transverse aortic
constriction. DSCR1 mRNA was markedly induced in the left ventricles of
banded mice compared with those of sham-operated mice at both 4 and 12 wk after surgical operations (Fig.
8).
|
| |
DISCUSSION |
|---|
|
|
|---|
These data demonstrate that biomechanical strain directly induces the DSCR1 gene, which encodes a calcineurin inhibitory protein in cardiac myocytes. The induction of DSCR1 mRNA by mechanical strain was time and amplitude dependent. In addition, mechanical induction of DSCR1 mRNA was angiotensin II and endothelin independent and was partially blocked by calcineurin inhibition. To our knowledge, this is the first report that mechanical strain directly regulates calcineurin activity and its inhibitory protein DSCR1 in cardiac myocytes. The induction of DSCR1 mRNA expression by cyclic mechanical strain in cardiac myocytes was rapid and highly reproducible. Increased DSCR1 mRNA was detected within 15 min after mechanical stimulation, suggesting a rapid feedback mechanism for regulating the calcineurin system. Yang and colleagues (28) recently reported that the DSCR1 gene is responsive to calcineurin signaling, whereas a second calcineurin inhibitor (MCIP2) was not calcineurin responsive. Our results show that mechanical induction of DSCR1 mRNA is intracellular Ca2+ dependent and partially dependent on calcineurin signaling, suggesting that other Ca2+-dependent mechanisms may also play a role in the regulation of DSCR1 expression.
DSCR1 mRNA is upregulated in a mouse model of pressure overload-induced hypertrophy. The induction of DSCR1 mRNA by pressure overload was persistent for at least 12 wk after aortic banding. This raises an interesting issue of what responses to mechanical overload are sustained versus transient. It has been reported that pressure overload increases calcineurin activity in the heart. The increase of calcineurin activity can be detected as early as 30 min and persists for at least 3 wk (14, 22, 30). Therefore, we speculate that the sustained increase of DSCR1 mRNA expression is an adaptive response to a persistent increase of calcineurin activity caused by pressure overload. In addition, pressure overload activates neurohumoral factors that upregulate DSCR1 gene expression in cultured cardiac myocytes; these factors may play a role in the sustained induction of DSCR1 mRNA expression. It would be useful to show that the DSCR1 protein expression increases in response to pressure overload. However, there is currently no antibody widely available to study protein expression.
Calcineurin is a serine-threonine protein phosphatase that participates
in a wide variety of biological responses, including lymphocyte
activation, neuronal and muscle development, axonal pathfinding, and
morphogenesis of vertebrate heart valves (3). Calcineurin
may be subjected to negative regulation by proteins that reduce its
ability to dephosphorylate substrates such as NF-ATc family members,
thereby preventing their nuclear localization (3). Recent
studies have implicated a role for calcineurin-dependent signaling
pathways in cardiac hypertrophy. Molkentin and associates (17) reported that overexpression of a truncated
constitutively active calcineurin A induces cardiac hypertrophy.
Furthermore, cyclosporin A prevents the development of cardiac
hypertrophy in response to some, but apparently not all, hypertrophic
stimuli (5, 14, 23). Recently, Rothermel et al.
(19) reported that forced overexpression of DSCR1 under
control of the cardiac specific,
-myosin heavy chain promoter
attenuated cardiac hypertrophy induced by cardiac specific expression
of a constitutively active form of calcineurin,
-adrenergic receptor
stimulation, or exercise training. The present study supports the
concept that endogenous negative feedback regulation of calcineurin
activity may occur both in vitro and in vivo. This raises the
intriguing possibility that one reason that several studies have
reached different conclusions regarding the role of calcineurin role in
cardiac hypertrophy is different degrees of negative feedback by
endogenous inhibitors such as DSCR1. It is important to recognize that
other unknown mechanisms of calcineurin inhibition or inactivation may
also play a role in the reduction of calcineurin activity.
In preliminary studies in our laboratory with DNA microarrays with the conditions used in this study, DSCR1 is among a very small subset of biomechanically induced genes in cardiac myocytes (~5 genes per 1,000 increased at least twofold). This suggests that induction of DSCR1 mRNA is part of a restricted molecular response to biomechanical stimuli, similar to our prior observations in vascular smooth muscle cells (4). Further studies of the mechanisms controlling DSCR1 gene induction by mechanical strain may lead to new understanding of cardiac hypertrophy.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-62943 (to R. T. Lee) and HL-67554 (to Y. Wang).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: R. T. Lee, Cardiovascular Division, Brigham and Women's Hospital, Partners Research Facility, Rm. 279, 65 Landsdowne St., Cambridge, MA 02139 (E-mail: rlee{at}rics.bwh.harvard.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
April 4, 2002;10.1152/ajpheart.00002.2002
Received 3 January 2002; accepted in final form 3 April 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Calaghan, SC,
and
White E.
The role of calcium in the response of cardiac muscle to stretch.
Prog Biophys Mol Biol
71:
59-90,
1999[ISI][Medline].
2.
Cheng, GC,
Briggs WH,
Gerson DS,
Libby P,
Grodzinsky AJ,
Gray ML,
and
Lee RT.
Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells.
Circ Res
80:
28-36,
1997
3.
Crabtree, GR.
Calcium, calcineurin, and the control of transcription.
J Biol Chem
276:
2313-2316,
2001
4.
Feng, Y,
Yang JH,
Huang H,
Kennedy SP,
Turi TG,
Thompson JF,
Libby P,
and
Lee RT.
Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells.
Circ Res
85:
1118-1123,
1999
5.
Force, T,
Rosenzweig A,
Choukroun G,
and
Hajjar R.
Calcineurin inhibitors and cardiac hypertrophy.
Lancet
353:
1290-1292,
1999[ISI][Medline].
6.
Fuentes, JJ,
Genesca L,
Kingsbury TJ,
Cunningham KW,
Perez-Riba M,
Estivill X,
and
de la Luna S.
DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.
Hum Mol Genet
9:
1681-1690,
2000
7.
Fuentes, JJ,
Pritchard MA,
Planas AM,
Ferrer I,
and
Estivill X.
A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart.
Hum Mol Genet
4:
1935-1944,
1995
8.
Kapadia, S,
Dibbs Z,
Kurrelmeyer K,
Kalra D,
Seta Y,
Wang F,
Bozkurt B,
Oral H,
Sivasubramanian N,
and
Mann DL.
The role of cytokines in the failing human heart.
Cardiol Clin
16:
645-656,
1998[Medline].
9.
Kingsbury, TJ,
and
Cunningham KW.
A conserved family of calcineurin regulators.
Genes Dev
14:
1595-1604,
2000
10.
Klee, CB,
Ren H,
and
Wang X.
Regulation of the calmodulin-stimulated protein phosphatase, calcineurin.
J Biol Chem
273:
13367-13370,
1998
11.
Komuro, I,
Katoh Y,
Kaida T,
Shibazaki Y,
Kurabayashi M,
Hoh E,
Takaku R,
and
Yazaki Y.
Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes: possible role of protein kinase C activation.
J Biol Chem
266:
1265-1268,
1991
12.
Komuro, I,
and
Yazaki Y.
Control of cardiac gene expression by mechanical stress.
Annu Rev Physiol
55:
55-75,
1993[ISI][Medline].
13.
Levy, D,
Garrison RJ,
Savage DD,
Kannel WB,
and
Castelli WP.
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
N Engl J Med
322:
1561-1566,
1990[Abstract].
14.
Lim, HW,
De Windt LJ,
Steinberg L,
Taigen T,
Witt SA,
Kimball TR,
and
Molkentin JD.
Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Circulation
101:
2431-2437,
2000
15.
Luo, Z,
Shyu KG,
Gualberto A,
and
Walsh K.
Calcineurin and cardiac hypertrophy.
Nat Med
10:
1092-1093,
1998.
16.
Molkentin, JD.
Calcineurin and beyond: cardiac hypertrophic signaling.
Circ Res
87:
731-738,
2000
17.
Molkentin, JD,
Lu JR,
Antos CL,
Markham B,
Richardson J,
Robbins J,
Grant SR,
and
Olson EN.
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
Cell
93:
215-228,
1998[ISI][Medline].
18.
Morgan, HE,
and
Baker KM.
Cardiac hypertrophy: mechanical, neural, and endocrine dependence.
Circulation
83:
13-25,
1991
19.
Rothermel, BA,
McKinsey TA,
Vega RB,
Nicol RL,
Mammen P,
Yang J,
Antos CL,
Shelton JM,
Bassel-Duby R,
Olson EN,
and
Williams RS.
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
Proc Natl Acad Sci USA
98:
3328-3333,
2001
20.
Rothermel, B,
Vega RB,
Yang J,
Wu H,
Bassel-Duby R,
and
Williams RS.
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.
J Biol Chem
275:
8719-8725,
2000
21.
Sadoshima, J,
and
Izumo S.
The cellular and molecular response of cardiac myocytes to mechanical stress.
Annu Rev Physiol
59:
551-571,
1997[ISI][Medline].
22.
Shimoyama, M,
Hayashi D,
Takimoto E,
Zou Y,
Oka T,
Uozumi H,
Kudoh S,
Shibasaki F,
Yazaki Y,
Nagai R,
and
Komuro I.
Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Circulation
100:
2449-2454,
1999
23.
Sussman, MA,
Lim HW,
Gude N,
Taigen T,
Olson EN,
Robbins J,
Colbert MC,
Gualberto A,
Wieczorek DF,
and
Molkentin JD.
Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
Science
281:
1690-1693,
1998
24.
Yamamoto, K,
Dang QN,
Kennedy SP,
Osathanondh R,
Kelly RA,
and
Lee RT.
Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species.
J Biol Chem
274:
21840-21846,
1999
25.
Yamamoto, K,
Dang QN,
Maeda Y,
Huang H,
Kelly RA,
and
Lee RT.
Regulation of cardiomyocyte mechanotransduction by the cardiac cycle.
Circulation
103:
1459-1464,
2001
26.
Yamazaki, T,
Komuro I,
Shiojima I,
Zou Y,
Shiojima I,
Mizuno T,
Takano H,
Hiroi Y,
Ueki K,
and
Tobe K.
Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes.
J Clin Invest
96:
438-446,
1995[ISI][Medline].
27.
Yamazaki, T,
Tobe K,
Hoh E,
Maemura K,
Kaida T,
Komuro I,
Tamemoto H,
Kadowaki T,
Nagai R,
and
Yazaki Y.
Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes.
J Biol Chem
268:
12069-12076,
1993
28.
Yang, J,
Rothermel B,
Vega RB,
Frey N,
McKinsey TA,
Olson EN,
Bassel-Duby R,
and
Williams RS.
Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.
Circ Res
87:
E61-E68,
2000
29.
Zhu, W,
Zou Y,
Shiojima I,
and
Kudoh S.
Ca2+/calmodulin-dependent kinase I.I. and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy.
J Biol Chem
275:
15239-15245,
2000
30.
Zou, Y,
Hiroi Y,
Uozumi H,
Takimoto E,
Toko H,
Zhu W,
Kudoh S,
Mizukami M,
Shimoyama M,
Shibasaki F,
Nagai R,
Yazaki Y,
and
Komuro I.
Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.
Circulation
104:
97-101,
2001
This article has been cited by other articles:
![]() |
Y. G. Ni, K. Berenji, N. Wang, M. Oh, N. Sachan, A. Dey, J. Cheng, G. Lu, D. J. Morris, D. H. Castrillon, et al. Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling Circulation, September 12, 2006; 114(11): 1159 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Yu and B. Russell Cardiomyocyte Remodeling and Sarcomere Addition after Uniaxial Static Strain In Vitro J. Histochem. Cytochem., July 1, 2005; 53(7): 839 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Hardt and J. Sadoshima Negative regulators of cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 500 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mansour, P. P. de Tombe, A. M. Samarel, and B. Russell Restoration of Resting Sarcomere Length After Uniaxial Static Strain Is Regulated by Protein Kinase C{epsilon} and Focal Adhesion Kinase Circ. Res., March 19, 2004; 94(5): 642 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Weinberg, M. Mirotsou, J. Gannon, V. J. Dzau, R. T. Lee, and R. E. Pratt Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload Physiol Genomics, January 15, 2003; 12(2): 113 - 127. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |